Stepwise Stapler is a laparoscopic device for vastly superior tissue closure

Projektinformationen

Stepwise

ID Finanzhilfevereinbarung: 761976

DOI 10.3030/761976

Abgeschlossenes Projekt

EK-Unterschriftsdatum 24 Januar 2017

Startdatum 1 Februar 2017

Enddatum 31 Mai 2017

Finanziert unter

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Gesamtkosten € 71 429,00

EU-Beitrag € 50 000,00

Koordiniert durch

STEPWISE LTD
Israel

Ziel

Stepwise Stapler is a proprietary engineered laparoscopic device. It carries out important tissue closure at the end of laparoscopic surgical procedures, providing vastly superior outcomes and greatly minimised fall-out compared to current closure devices

Its adoption will bring improved patient healing outcomes, reduced medical infrastructure burden, and reduced financial burden to patients, the state, and medical insurers.

Members of Stepwise’s core team have already attained instrumental experience through the successful commercialization of laparoscopy devices through startup Eon surgical; which was successfully acquired by multi-national firm Teleflex. This same expertise would bring Stepwise to similar footing in the product and market development process to bring its product to even greater heights. The core team includes over 80 years’ expertise involving mechanical engineering, biomedical engineering, and surgery.

The proposed work in Phase 1 of the SME instrument fits into Stepwise’s overall plan to carry out a full assessment for its business model, on whether sales of the product under the Stepwise brand name, or licensing to an established brand would be more feasible. It would also allow Stepwise to confirm its OEM contract manufacturer, considering the material specifications, their specialities, and logistical connections to ensure a seamless supply chain

Wissenschaftliches Gebiet

• medical and health sciences › medical biotechnology
• social sciences › economics and business › business and management › business models
• engineering and technology › mechanical engineering

Programm/Programme

• H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme
• H2020-EU.3.1.3. - Treating and managing disease

Thema/Themen

• SMEInst-05-2016-2017 - Supporting innovative SMEs in the healthcare biotechnology sector

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2016-2017

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-1-2016-2017

Finanzierungsplan

SME-1 - SME instrument phase 1

Koordinator

STEPWISE LTD

• Netto-EU-Beitrag: € 50 000,00
• Adresse: OR TOWERS, 27 HABARZEL ST ; 6971039 TEL AVIV ; Israel
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Aktivitätstyp
  Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 71 429,00